Literature DB >> 21108465

Robust genital gag-specific CD8+ T-cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV-1-gag.

Larissa H Haut1, Shih W Lin, Nia Tatsis, Lauren J DiMenna, Wynetta Giles-Davis, Aguinaldo R Pinto, Hildegund C J Ertl.   

Abstract

Most studies on E1-deleted adenovirus (Ad) vectors as vaccine carriers for antigens of HIV-1 have focused on induction of central immune responses, although stimulation of mucosal immunity at the genital tract (GT), the primary port of entry of HIV-1, would also be highly desirable. In this study, different immunization protocols using chimpanzee-derived adenoviral (AdC) vectors expressing Gag of HIV-1 clade B given in heterologous prime-boost regimens were tested for induction of systemic and genital immune responses. Although i.n. immunization stimulated CD8(+) T-cell responses that could be detected in the GT, this route induced only marginal cellular responses in systemic tissues and furthermore numbers of Gag-specific CD8(+) T cells contracted sharply within a few weeks. On the contrary, i.m. immunization induced higher and more sustained frequencies of vaccine-induced cells which could be detected in the GT as well as systemic compartments. Antigen-specific CD8(+) T cells could be detected 1 year after immunization in all compartments analyzed. Genital memory cells secreted IFN-γ, expressed high levels of CD103 and their phenotypes were consistent with a state of activation. Taken together, the results presented here show that i.m. vaccination with chimpanzee-derived (simian) adenovirus vectors is a suitable strategy to induce a long-lived genital CD8(+) T-cell response.
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21108465      PMCID: PMC3154578          DOI: 10.1002/eji.201040440

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  36 in total

1.  Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.

Authors:  Arguinaldo R Pinto; Julie C Fitzgerald; Wynetta Giles-Davis; Guang Ping Gao; James M Wilson; Hildegund C J Ertl
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

Review 2.  Roles of the NKG2D immunoreceptor and its ligands.

Authors:  David H Raulet
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

3.  Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors.

Authors:  Soumitra Roy; Guangping Gao; You Lu; Xiangyang Zhou; Martin Lock; Roberto Calcedo; James M Wilson
Journal:  Hum Gene Ther       Date:  2004-05       Impact factor: 5.695

4.  Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing.

Authors:  Nia Tatsis; Shih-Wen Lin; Kimberly Harris-McCoy; David A Garber; Mark B Feinberg; Hildegund C J Ertl
Journal:  Virology       Date:  2007-06-27       Impact factor: 3.616

5.  Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo.

Authors:  R A Hawkins; R G Rank; K A Kelly
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251.

Authors:  Liljana Stevceva; Brian Kelsall; Janos Nacsa; Marcin Moniuszko; Zdenek Hel; Elzbieta Tryniszewska; Genoveffa Franchini
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier.

Authors:  Z Q Xiang; G P Gao; A Reyes-Sandoval; Y Li; J M Wilson; H C J Ertl
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

Authors:  Julie C Fitzgerald; Guang-Ping Gao; Arturo Reyes-Sandoval; George N Pavlakis; Zhi Q Xiang; Anthony P Wlazlo; Wynetta Giles-Davis; James M Wilson; Hildegund C J Ertl
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

9.  Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes.

Authors:  A Reyes-Sandoval; J C Fitzgerald; R Grant; S Roy; Z Q Xiang; Y Li; G P Gao; J M Wilson; H C J Ertl
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.

Authors:  Zhiquan Xiang; Guangping Gao; Arturo Reyes-Sandoval; Christopher J Cohen; Yan Li; Jeffrey M Bergelson; James M Wilson; Hildegund C J Ertl
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

View more
  7 in total

1.  The effect of adenovirus-specific antibodies on adenoviral vector-induced, transgene product-specific T cell responses.

Authors:  Juliana C Small; Larissa H Haut; Ang Bian; Hildegund C J Ertl
Journal:  J Leukoc Biol       Date:  2014-07-31       Impact factor: 4.962

2.  Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.

Authors:  Nicolas Çuburu; Barney S Graham; Christopher B Buck; Rhonda C Kines; Yuk-Ying S Pang; Patricia M Day; Douglas R Lowy; John T Schiller
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

3.  T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load.

Authors:  Yaowaluck Roshorm; Mathew G Cottingham; Mary-Jane Potash; David J Volsky; Tomáš Hanke
Journal:  Eur J Immunol       Date:  2012-10-16       Impact factor: 5.532

4.  Enhancement of recombinant adenovirus vaccine-induced primary but not secondary systemic and mucosal immune responses by all-trans retinoic acid.

Authors:  Steven Tuyishime; Larissa H Haut; Caihong Zhu; Hildegund C J Ertl
Journal:  Vaccine       Date:  2014-04-26       Impact factor: 3.641

5.  Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaques.

Authors:  Marcio O Lasaro; Larissa H Haut; Xiangyang Zhou; Zhiquan Xiang; Dongming Zhou; Yan Li; Wynetta Giles-Davis; Hua Li; Jessica C Engram; Lauren J Dimenna; Ang Bian; Marina Sazanovich; Elizabeth M Parzych; Raj Kurupati; Juliana C Small; Te-Lang Wu; Rachel M Leskowitz; Nicole R Klatt; Jason M Brenchley; David A Garber; Mark Lewis; Sarah J Ratcliffe; Michael R Betts; Guido Silvestri; Hildegund C Ertl
Journal:  Mol Ther       Date:  2010-11-16       Impact factor: 11.454

6.  Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination.

Authors:  Susan A Holechek; Megan S McAfee; Lizbeth M Nieves; Vanessa P Guzman; Kavita Manhas; Timothy Fouts; Kenneth Bagley; Joseph N Blattman
Journal:  Vaccine       Date:  2016-09-23       Impact factor: 3.641

Review 7.  The influence of delivery vectors on HIV vaccine efficacy.

Authors:  Beatrice O Ondondo
Journal:  Front Microbiol       Date:  2014-08-22       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.